GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Long-Term Debt Issuances (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Long-Term Debt Issuances came in at $700000.0 in Q1 2025, up 209.71% on a YoY basis from $226015.0 in Q1 2024, and up 14.23% quarter-over-quarter from $612784.0 in Q4 2024.

Analysis

GridAI Technologies (GRDX) Long-Term Debt Issuances (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has reported Long-Term Debt Issuances for 11 consecutive years, with $700000.0 the latest figure, recorded in Q1 2025.

  • For the quarter ending Q1 2025, Long-Term Debt Issuances rose 209.71% year-over-year to $700000.0; the trailing twelve-month figure through Sep 2025 stood at $1.3 million (up 608.56% YoY), and the FY2025 full-year result was $2.3 million, up 256.82% from the prior year.
  • Long-Term Debt Issuances advanced to $700000.0 in Q1 2025 per GRDX's latest filing, from $612784.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $700000.0 in Q1 2025 and bottomed at -$552405.0 in Q4 2021.
  • Historically, Long-Term Debt Issuances has averaged $184950.9 across 5 years, with a median of $215308.5 in 2021.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Debt Issuances sank 185.59% in 2024, then jumped 209.71% in 2025.
  • Over 5 years, Long-Term Debt Issuances stood at -$552405.0 in 2021, then jumped by 129.31% to $161909.0 in 2022, then retreated by 5.21% to $153478.0 in 2023, then surged by 299.27% to $612784.0 in 2024, then gained by 14.23% to $700000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $700000.0, $612784.0, and -$194217.0 for Q1 2025, Q4 2024, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.32 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 700,000.00
Dec 31, 2024 612,784.00
Jun 30, 2024 -194,217.00
Mar 31, 2024 226,015.00
Sep 30, 2023 153,478.00
Jun 30, 2023 226,912.00
Mar 31, 2023 223,104.00
Sep 30, 2022 161,909.00
Jun 30, 2022 240,857.00
Mar 31, 2022 238,470.00
Dec 31, 2021 -552,405.00
Sep 30, 2021 139,569.00
Jun 30, 2021 207,513.00
Mar 31, 2021 205,323.00
Mar 31, 2020 3.23 Mn
Dec 31, 2019 2.97 Mn
Mar 31, 2019 2.00 Mn
Dec 31, 2018 127,023.00
Sep 30, 2018 26,836.00
Jun 30, 2018 53,303.00